If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOte Ads Regulatory News (OTES)

Share Price Information for Ote Ads (OTES)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.06274
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 6.06274
High: 0.00
Low: 0.00
Prev. Close: 6.06274
OTES Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Announcement of Regulated Information-Bonds Issue

14 May 2021 16:03

RNS Number : 7335Y
Hellenic Telecomms Organization S A
14 May 2021
 

Announcement of Regulated Information

 

 

 

 

Athens, 14 May 2021 - Hellenic Telecommunications Organization S.A. ("OTE SA") announces that its subsidiary OTE plc, with registered seat in the UK, issued today €150 million notes due November 2021 and €200 million notes due May 2028. The yield of the notes was set at -0.237% per annum and 0.627% per annum respectively. The new notes were fully subscribed by Deutsche Telekom AG.

 

The new notes were issued by OTE plc and guaranteed by ΟΤΕ SA under the existing Global Medium Term Note Programme, governed by English Law, and are not listed for trading. Settlement was executed today 14 May 2021.

 

The proceeds of the new notes will be used for the refinancing of the €200 million OTE plc notes, maturing in June 2021, as well as for general corporate purposes of OTE Group.

 

The announcement is issued as a Regulated Information, in accordance with Law 3556/2007, [article 3, par. 1 (p) and article 21] and Regulation No 596/2014 (article 17) of the European Parliament and of the Council on market abuse.

 

 

 

FOR FURTHER INFORMATION:

 

OTE GROUP INVESTOR RELATIONS

Τel. +0030 210-6117364

Fax: +0030 210-6111030

E-mail: iroffice@ote.gr

 

 

 

NOTE: This announcement is published in accordance with the applicable provisions of, amongst others, Regulation (EU) No 596/2014 and the Rule Book (Regulation) of the Athens Exchange.

 

This announcement is not an offer of securities for sale in the United States or any other jurisdiction where to do so would be unlawful. The notes referred to in this announcement have not been and will not be registered in any jurisdiction and neither OTE SA nor OTE PLC intends to conduct a public offering of securities in any jurisdiction. In particular, no securities of OTE SA or OTE PLC have been or will be registered under the U.S. Securities Act of 1933, as amended (the Securities Act), and the notes referred to in this announcement may not be offered, sold or delivered within the United States or to, or for the account or benefit of, U.S. persons (as defined in Regulation S under the Securities Act) except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.

 

The offering of the notes referred to in this announcement is not being made, directly or indirectly, to the public in the Hellenic Republic (Greece). None of this announcement and any other documents or materials relating to the notes referred to herein constitute an "offer of securities to the public" as defined in Regulation (EU) 2017/1129 (the "Prospectus Regulation"), for the purchase, sale or exchange of, or otherwise for an investment in, securities in the territory of Greece. Accordingly, neither this announcement nor any other documents or materials relating to such notes have or will be submitted to the Hellenic Capital Market Commission for approval pursuant to the Prospectus Regulation. No offer of securities will be made in Greece other than in accordance with an exemption under the Prospectus Regulation (as defined below).

 

This document is an advertisement and is not a prospectus for the purposes of the Prospectus Regulation. The Final Terms for the notes referred to herein, supplementing the Base Prospectus (dated 10 April 2019, as supplemented on 12 September 2019) will be published on the website of the Luxembourg Stock Exchange at www.bourse.lu. Investors should not subscribe for any transferable securities referred to in this document other than on the basis of information contained in the relevant Final Terms and the Base Prospectus, as supplemented.

 

This document is not being distributed to, and must not be passed on to, the general public in the United Kingdom. The communication of this document as a financial promotion is only being made to those persons falling within Article 12, Article 19(5) or Article 49 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 or to other persons to whom this document may otherwise be distributed without contravention of section 21 of the Financial Services and Markets Act 2000, or any person to whom it may otherwise lawfully be made(all such persons being together referred to as "relevant persons"). Any investment or investment activity relating to the notes is available only to relevant persons and will be engaged in only with relevant persons. Each recipient also represents and agrees that it has complied and will comply with all applicable provisions of the Financial Services Markets Act 2000 with respect to anything done by it in relation to any notes in, from or otherwise involving the United Kingdom. The notes are not being offered to the public in the United Kingdom.

 

MIFID II product governance / High net worth retail investors, professional investors and ECPs target market - Solely for the purposes of each manufacturer's product approval process, the target market assessment in respect of the Notes has led to the conclusion that: (i) the target market for the Notes is eligible counterparties and professional clients, each as defined in Directive 2014/65/EU (as amended, "MiFID II") and retail clients (as defined in MiFID II) that are in a financial situation to be able to bear a loss of their entire investment in the Notes; (ii) all channels for distribution of the Notes to eligible counterparties and professional clients are appropriate; and (iii) the following channels for distribution of the Notes to such retail clients are appropriate - investment advice, portfolio management, non-advised sales and pure execution services - subject to the distributor's suitability and appropriateness obligations under MiFID II, as applicable. Any person subsequently offering, selling or recommending the Notes (a "distributor") should take into consideration the manufacturers' target market assessment; however, a distributor subject to MiFID II is responsible for undertaking its own target market assessment in respect of the Notes (by either adopting or refining the manufacturers' target market assessment) and determining appropriate distribution channels, subject to the distributor's suitability and appropriateness obligations under MiFID II.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IODGZGMKKDGGMZM
Date   Source Headline
21st Jul 202310:51 amRNSPurchase of Own Shares
14th Jul 20239:29 amRNSCancellation & Deletion of Own Shares
14th Jul 20238:45 amRNSPurchase of Own Shares
13th Jul 20233:44 pmRNSAnnouncement-absorption of COSMOTE by OTE
7th Jul 20238:25 amRNSPurchase of Own Shares
3rd Jul 20234:23 pmRNSAnnouncement-Dividend Distribution of FY 2022
3rd Jul 202311:32 amRNSRelease Date of Q2/2023 Results
30th Jun 20238:04 amRNSPurchase of Own Shares
23rd Jun 20238:14 amRNSPurchase of Own Shares
22nd Jun 20233:56 pmRNSAnnouncement of Regulated Information - Bond Issue
16th Jun 20238:19 amRNSPurchase of Own Shares
12th Jun 20231:26 pmRNSVoting Results of OTE AGM
9th Jun 20239:09 amRNSPurchase of Own Shares
7th Jun 20233:53 pmRNSResolutions of OTE AGM June 07, 2023
2nd Jun 20238:33 amRNSPurchase of Own Shares
26th May 20239:08 amRNS(Correct Repetition) Purchase of Own Shares
26th May 20238:07 amRNSPurchase of Own Shares
19th May 20238:22 amRNSPurchase of Own Shares
17th May 20233:57 pmRNSInvitation to the 71st AGM
12th May 20237:44 amRNSPurchase of Own Shares
5th May 202310:16 amRNSPurchase of Own Shares
5th May 20238:32 amRNSAnnouncement-Q12023 Financial Results
2nd May 202310:50 amRNSAnnouncement-change of CEO in TKRM
28th Apr 20238:03 amRNSPurchase of Own Shares
21st Apr 20238:11 amRNSPurchase of own shares
12th Apr 20231:12 pmRNSPurchase of Own Shares
6th Apr 202311:31 amRNSPurchase of Own Shares
5th Apr 202310:12 amRNSRelease Date of Q1 2023 Results
31st Mar 20238:24 amRNSPurchase of Own Shares
23rd Mar 20233:40 pmRNSAnnouncement-Purchase of own shares
17th Mar 20238:08 amRNSPurchase of own shares
10th Mar 20238:28 amRNSPurchase of Own Shares
7th Mar 20239:30 amRNSPurchase of own shares
2nd Mar 202311:01 amRNSAnnouncement of regulated information
24th Feb 20238:57 amRNSAnnouncement - Own Share Buyback Intention
23rd Feb 20239:17 amRNSPress Release Q4'2022 Results
10th Feb 202310:31 amRNSAnnouncement of regulated information
24th Jan 202311:44 amRNSFinancial Calendar 2023
23rd Jan 202310:15 amRNSRelease Date Of Q4 2022 Financial Results
9th Dec 202212:34 pmRNSPurchase of own shares
9th Dec 202212:33 pmRNSPurchase of own shares
8th Dec 20222:55 pmRNSAnnouncement of regulated information
29th Nov 202210:25 amRNSAnnouncement of Regulated Information
29th Nov 20228:41 amRNSPurchase of own shares
25th Nov 20229:00 amRNSCancellation & Deletion of own shares
22nd Nov 20228:11 amRNSPurchase of own shares
15th Nov 20229:18 amRNSPurchase of own shares
11th Nov 20221:48 pmRNSAnnouncement of regulated information
10th Nov 20228:16 amRNS3rd Quarter Results 2022
9th Nov 20229:43 amRNSPurchase of own shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.